乳腺癌中的免疫检查点阻断与新兴联合平台:叙述性综述
Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Review.
52.6分
★★★☆☆
站内排序·非疗效
DISEASE HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Review.
Chimeric antigen receptor-based immunotherapy in breast cancer: Recent progress in China.
CAR-T/NK/M-based combination therapies in cancer: A comprehensive review.
Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.
MEMBER ACCOUNT
登录成功会直接打开下一页。